CASI - CASI Pharmaceuticals GAAP EPS of -$0.06 beats by $0.03 revenue of $9.06M misses by $0.18M
CASI Pharmaceuticals press release (NASDAQ:CASI): Q1 GAAP EPS of -$0.06 beats by $0.03. Revenue of $9.06M (+57.8% Y/Y) misses by $0.18M.
For further details see:
CASI Pharmaceuticals GAAP EPS of -$0.06 beats by $0.03, revenue of $9.06M misses by $0.18M